Table 5.
Complications
| Study | Treatment group | Number of patients | Arthrofibrosis | Superficial wound infection | Tissue hypertrophy | Reactive synovitis | Deep venous thrombosis | Postoperative hemarthrosis | Proud osteochondral graft |
|---|---|---|---|---|---|---|---|---|---|
| Gudas et al. [19] | OAT | 28 | 2 (7.1%) | 1 (3.6%) | |||||
| Microfracture | 29 | 1 (3.4%) | |||||||
| Bartlett et al. [1] | ACI-C | 44 | 3 (6.8%) | 4 (9.1%) | |||||
| MACI | 47 | 3 (6.4%) | 1 (2.1%) | 3 (6.4%) | |||||
| Knutsen et al. [29] | ACI-P | 40 | 10 (25%) | ||||||
| Microfracture | 40 | 1 (2.5%) | 3 (7.5%) | ||||||
| Visna et al. [45] | MACI | 25 | 6 (24%) | ||||||
| Abrasion | 25 | ||||||||
| Bentley et al. [2] | ACI-P/C | 58 | |||||||
| OAT | 42 | 3 (7.1%) | 1 (2.4%) | 1 (2.4%) | |||||
| Horas et al. [24] | ACI-P | 20 | 3 (15%) | ||||||
| OAT | 20 | 3 (15%) | 1 (5%) | 2 (10%) |
OAT = osteochondral allograft transfer; ACI-C = autologous chondrocyte implantation–collagen cover; MACI = matrix-induced autologous chondrocyte implantation; ACI-P = autologous chondrocyte implantation–periosteal cover.